TB Alliance Names Sandeep Juneja as Senior Vice President for Market Access
NEW YORK (June 4, 2018) – TB Alliance today announced the appointment of Sandeep Juneja to Senior Vice President for
News
Press Releases
Global MPs Urge Heads of State to Act on Tuberculosis
NEW YORK (April 26, 2018) – In a statement released on Thursday, members of the Global TB Caucus, a group
Nancy Miller-Rich Joins TB Alliance Board of Directors
NEW YORK (March 6, 2018)—TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight tuberculosis
ZeNix Clinical Trial Announced
NEW YORK (7 February, 2018) — TB Alliance has announced the start of a clinical trial of a three-drug regimen
Ending TB Means Investing in R&D
This week, as health ministers, diplomats and other representatives meet to discuss tuberculosis (TB) at the World Health Organization (WHO)
Ariel Pablos-Méndez Joins TB Alliance Board of Directors
NEW YORK (November 6, 2017)—TB Alliance today announced the appointment of Dr. Ariel Pablos-Méndez to its board of directors. As
TB Alliance Statement on WHO’s Global Tuberculosis Report 2017
The World Health Organization’s (WHO) 2017 Global Tuberculosis Report, released today, showed a reduction in TB deaths in 2016 compared
TB Alliance Moves Two Novel Tuberculosis Drugs into Human Trials
GUADALAJARA (10 October, 2017) — TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have
TB Alliance Endorses WHO Designation of TB as a “Global Priority Pathogen”
NEW YORK (27 September, 2017)—TB Alliance commends the World Health Organization (WHO) for recognizing tuberculosis (TB) as a priority pathogen
WHO Prequalifies Childhood TB Medicine
The World Health Organization (WHO) has just prequalified a two-pills-in-one pediatric medicine that is critical for the continuation phase of